nodes	percent_of_prediction	percent_of_DWPC	metapath
Clomipramine—GSTP1—Chlorambucil—testicular cancer	0.38	0.465	CbGbCtD
Clomipramine—GSTP1—Carboplatin—testicular cancer	0.123	0.15	CbGbCtD
Clomipramine—GSTP1—Cisplatin—testicular cancer	0.105	0.128	CbGbCtD
Clomipramine—GSTP1—Etoposide—testicular cancer	0.103	0.126	CbGbCtD
Clomipramine—CYP2C19—Ifosfamide—testicular cancer	0.0175	0.0214	CbGbCtD
Clomipramine—ABCB1—Dactinomycin—testicular cancer	0.0119	0.0146	CbGbCtD
Clomipramine—ALB—Methotrexate—testicular cancer	0.00851	0.0104	CbGbCtD
Clomipramine—CYP3A4—Ifosfamide—testicular cancer	0.00844	0.0103	CbGbCtD
Clomipramine—CYP1A2—Etoposide—testicular cancer	0.0077	0.00943	CbGbCtD
Clomipramine—ABCB1—Vinblastine—testicular cancer	0.00748	0.00915	CbGbCtD
Clomipramine—CYP2D6—Vinblastine—testicular cancer	0.00704	0.00863	CbGbCtD
Clomipramine—ABCB1—Cisplatin—testicular cancer	0.00685	0.00839	CbGbCtD
Clomipramine—ABCB1—Etoposide—testicular cancer	0.00673	0.00825	CbGbCtD
Clomipramine—ABCB1—Doxorubicin—testicular cancer	0.00459	0.00563	CbGbCtD
Clomipramine—CYP3A4—Vinblastine—testicular cancer	0.00448	0.00549	CbGbCtD
Clomipramine—ABCB1—Methotrexate—testicular cancer	0.00445	0.00545	CbGbCtD
Clomipramine—CYP2D6—Doxorubicin—testicular cancer	0.00433	0.0053	CbGbCtD
Clomipramine—CYP3A4—Etoposide—testicular cancer	0.00404	0.00494	CbGbCtD
Clomipramine—CYP3A4—Doxorubicin—testicular cancer	0.00275	0.00337	CbGbCtD
Clomipramine—HTR2A—vein—testicular cancer	0.000859	0.178	CbGeAlD
Clomipramine—GSTP1—embryo—testicular cancer	0.000369	0.0766	CbGeAlD
Clomipramine—GSTP1—seminal vesicle—testicular cancer	0.000347	0.072	CbGeAlD
Clomipramine—GSTP1—gonad—testicular cancer	0.000251	0.052	CbGeAlD
Clomipramine—GSTP1—female gonad—testicular cancer	0.000204	0.0423	CbGeAlD
Clomipramine—SLC6A2—gonad—testicular cancer	0.000184	0.0381	CbGeAlD
Clomipramine—HRH2—lymph node—testicular cancer	0.000182	0.0377	CbGeAlD
Clomipramine—GSTP1—testis—testicular cancer	0.000181	0.0375	CbGeAlD
Clomipramine—ADRA2A—seminal vesicle—testicular cancer	0.00018	0.0373	CbGeAlD
Clomipramine—HTR2A—embryo—testicular cancer	0.000163	0.0337	CbGeAlD
Clomipramine—ALB—testis—testicular cancer	0.000155	0.0321	CbGeAlD
Clomipramine—SLC6A2—testis—testicular cancer	0.000132	0.0275	CbGeAlD
Clomipramine—GSTP1—lymph node—testicular cancer	0.000131	0.0272	CbGeAlD
Clomipramine—ADRA2A—gonad—testicular cancer	0.00013	0.0269	CbGeAlD
Clomipramine—ALB—lymph node—testicular cancer	0.000112	0.0233	CbGeAlD
Clomipramine—HTR2A—gonad—testicular cancer	0.00011	0.0229	CbGeAlD
Clomipramine—HTR2B—lymph node—testicular cancer	0.000108	0.0224	CbGeAlD
Clomipramine—ABCB1—embryo—testicular cancer	0.000107	0.0221	CbGeAlD
Clomipramine—ADRA2A—female gonad—testicular cancer	0.000105	0.0219	CbGeAlD
Clomipramine—ABCB1—seminal vesicle—testicular cancer	0.0001	0.0208	CbGeAlD
Clomipramine—SLC6A2—lymph node—testicular cancer	9.59e-05	0.0199	CbGeAlD
Clomipramine—ADRA2A—testis—testicular cancer	9.35e-05	0.0194	CbGeAlD
Clomipramine—Body temperature increased—Etoposide—testicular cancer	8.22e-05	0.00046	CcSEcCtD
Clomipramine—Urinary tract infection—Doxorubicin—testicular cancer	8.22e-05	0.00046	CcSEcCtD
Clomipramine—Conjunctivitis—Doxorubicin—testicular cancer	8.22e-05	0.00046	CcSEcCtD
Clomipramine—Hepatitis—Epirubicin—testicular cancer	8.21e-05	0.00046	CcSEcCtD
Clomipramine—Eye disorder—Methotrexate—testicular cancer	8.2e-05	0.000459	CcSEcCtD
Clomipramine—Tinnitus—Methotrexate—testicular cancer	8.18e-05	0.000458	CcSEcCtD
Clomipramine—CYP2D6—female gonad—testicular cancer	8.17e-05	0.017	CbGeAlD
Clomipramine—Hypoaesthesia—Epirubicin—testicular cancer	8.17e-05	0.000457	CcSEcCtD
Clomipramine—Asthenia—Cisplatin—testicular cancer	8.15e-05	0.000456	CcSEcCtD
Clomipramine—Pharyngitis—Epirubicin—testicular cancer	8.15e-05	0.000456	CcSEcCtD
Clomipramine—Cardiac disorder—Methotrexate—testicular cancer	8.14e-05	0.000456	CcSEcCtD
Clomipramine—Sweating—Doxorubicin—testicular cancer	8.11e-05	0.000454	CcSEcCtD
Clomipramine—Urinary tract disorder—Epirubicin—testicular cancer	8.1e-05	0.000454	CcSEcCtD
Clomipramine—Haematuria—Doxorubicin—testicular cancer	8.07e-05	0.000452	CcSEcCtD
Clomipramine—Connective tissue disorder—Epirubicin—testicular cancer	8.06e-05	0.000452	CcSEcCtD
Clomipramine—Urethral disorder—Epirubicin—testicular cancer	8.05e-05	0.00045	CcSEcCtD
Clomipramine—Hepatobiliary disease—Doxorubicin—testicular cancer	8e-05	0.000448	CcSEcCtD
Clomipramine—Epistaxis—Doxorubicin—testicular cancer	7.98e-05	0.000447	CcSEcCtD
Clomipramine—Angiopathy—Methotrexate—testicular cancer	7.96e-05	0.000445	CcSEcCtD
Clomipramine—HTR2A—testis—testicular cancer	7.95e-05	0.0165	CbGeAlD
Clomipramine—Sinusitis—Doxorubicin—testicular cancer	7.94e-05	0.000444	CcSEcCtD
Clomipramine—Immune system disorder—Methotrexate—testicular cancer	7.92e-05	0.000444	CcSEcCtD
Clomipramine—Visual impairment—Epirubicin—testicular cancer	7.91e-05	0.000443	CcSEcCtD
Clomipramine—Mediastinal disorder—Methotrexate—testicular cancer	7.9e-05	0.000443	CcSEcCtD
Clomipramine—Agranulocytosis—Doxorubicin—testicular cancer	7.89e-05	0.000442	CcSEcCtD
Clomipramine—Chills—Methotrexate—testicular cancer	7.87e-05	0.000441	CcSEcCtD
Clomipramine—Nausea—Ifosfamide—testicular cancer	7.82e-05	0.000438	CcSEcCtD
Clomipramine—Diarrhoea—Cisplatin—testicular cancer	7.77e-05	0.000435	CcSEcCtD
Clomipramine—Alopecia—Methotrexate—testicular cancer	7.75e-05	0.000434	CcSEcCtD
Clomipramine—Bradycardia—Doxorubicin—testicular cancer	7.73e-05	0.000433	CcSEcCtD
Clomipramine—Mental disorder—Methotrexate—testicular cancer	7.68e-05	0.00043	CcSEcCtD
Clomipramine—Eye disorder—Epirubicin—testicular cancer	7.67e-05	0.000429	CcSEcCtD
Clomipramine—Hypersensitivity—Etoposide—testicular cancer	7.66e-05	0.000429	CcSEcCtD
Clomipramine—Tinnitus—Epirubicin—testicular cancer	7.65e-05	0.000428	CcSEcCtD
Clomipramine—Malnutrition—Methotrexate—testicular cancer	7.63e-05	0.000427	CcSEcCtD
Clomipramine—Flushing—Epirubicin—testicular cancer	7.62e-05	0.000426	CcSEcCtD
Clomipramine—Cardiac disorder—Epirubicin—testicular cancer	7.62e-05	0.000426	CcSEcCtD
Clomipramine—Rhinitis—Doxorubicin—testicular cancer	7.61e-05	0.000426	CcSEcCtD
Clomipramine—Hepatitis—Doxorubicin—testicular cancer	7.59e-05	0.000425	CcSEcCtD
Clomipramine—Hypoaesthesia—Doxorubicin—testicular cancer	7.56e-05	0.000423	CcSEcCtD
Clomipramine—Pharyngitis—Doxorubicin—testicular cancer	7.54e-05	0.000422	CcSEcCtD
Clomipramine—Urinary tract disorder—Doxorubicin—testicular cancer	7.5e-05	0.00042	CcSEcCtD
Clomipramine—Dysgeusia—Methotrexate—testicular cancer	7.48e-05	0.000419	CcSEcCtD
Clomipramine—Asthenia—Etoposide—testicular cancer	7.46e-05	0.000418	CcSEcCtD
Clomipramine—Connective tissue disorder—Doxorubicin—testicular cancer	7.46e-05	0.000418	CcSEcCtD
Clomipramine—Angiopathy—Epirubicin—testicular cancer	7.45e-05	0.000417	CcSEcCtD
Clomipramine—Urethral disorder—Doxorubicin—testicular cancer	7.44e-05	0.000417	CcSEcCtD
Clomipramine—Immune system disorder—Epirubicin—testicular cancer	7.41e-05	0.000415	CcSEcCtD
Clomipramine—Mediastinal disorder—Epirubicin—testicular cancer	7.4e-05	0.000414	CcSEcCtD
Clomipramine—Back pain—Methotrexate—testicular cancer	7.38e-05	0.000413	CcSEcCtD
Clomipramine—Chills—Epirubicin—testicular cancer	7.36e-05	0.000412	CcSEcCtD
Clomipramine—Pruritus—Etoposide—testicular cancer	7.36e-05	0.000412	CcSEcCtD
Clomipramine—Arrhythmia—Epirubicin—testicular cancer	7.33e-05	0.00041	CcSEcCtD
Clomipramine—Visual impairment—Doxorubicin—testicular cancer	7.32e-05	0.00041	CcSEcCtD
Clomipramine—Alopecia—Epirubicin—testicular cancer	7.25e-05	0.000406	CcSEcCtD
Clomipramine—CYP2D6—testis—testicular cancer	7.24e-05	0.015	CbGeAlD
Clomipramine—ABCB1—gonad—testicular cancer	7.23e-05	0.015	CbGeAlD
Clomipramine—Vomiting—Cisplatin—testicular cancer	7.22e-05	0.000404	CcSEcCtD
Clomipramine—Vision blurred—Methotrexate—testicular cancer	7.19e-05	0.000403	CcSEcCtD
Clomipramine—Mental disorder—Epirubicin—testicular cancer	7.19e-05	0.000403	CcSEcCtD
Clomipramine—Rash—Cisplatin—testicular cancer	7.16e-05	0.000401	CcSEcCtD
Clomipramine—Dermatitis—Cisplatin—testicular cancer	7.15e-05	0.0004	CcSEcCtD
Clomipramine—Malnutrition—Epirubicin—testicular cancer	7.14e-05	0.0004	CcSEcCtD
Clomipramine—Diarrhoea—Etoposide—testicular cancer	7.12e-05	0.000398	CcSEcCtD
Clomipramine—Eye disorder—Doxorubicin—testicular cancer	7.1e-05	0.000397	CcSEcCtD
Clomipramine—Ill-defined disorder—Methotrexate—testicular cancer	7.08e-05	0.000397	CcSEcCtD
Clomipramine—Tinnitus—Doxorubicin—testicular cancer	7.08e-05	0.000396	CcSEcCtD
Clomipramine—Anaemia—Methotrexate—testicular cancer	7.06e-05	0.000395	CcSEcCtD
Clomipramine—Flushing—Doxorubicin—testicular cancer	7.05e-05	0.000395	CcSEcCtD
Clomipramine—Cardiac disorder—Doxorubicin—testicular cancer	7.05e-05	0.000395	CcSEcCtD
Clomipramine—Flatulence—Epirubicin—testicular cancer	7.04e-05	0.000394	CcSEcCtD
Clomipramine—Tension—Epirubicin—testicular cancer	7.01e-05	0.000393	CcSEcCtD
Clomipramine—Dysgeusia—Epirubicin—testicular cancer	7e-05	0.000392	CcSEcCtD
Clomipramine—Nervousness—Epirubicin—testicular cancer	6.94e-05	0.000389	CcSEcCtD
Clomipramine—Back pain—Epirubicin—testicular cancer	6.91e-05	0.000387	CcSEcCtD
Clomipramine—Angiopathy—Doxorubicin—testicular cancer	6.89e-05	0.000386	CcSEcCtD
Clomipramine—Malaise—Methotrexate—testicular cancer	6.88e-05	0.000385	CcSEcCtD
Clomipramine—Dizziness—Etoposide—testicular cancer	6.88e-05	0.000385	CcSEcCtD
Clomipramine—Muscle spasms—Epirubicin—testicular cancer	6.87e-05	0.000385	CcSEcCtD
Clomipramine—Immune system disorder—Doxorubicin—testicular cancer	6.86e-05	0.000384	CcSEcCtD
Clomipramine—Vertigo—Methotrexate—testicular cancer	6.86e-05	0.000384	CcSEcCtD
Clomipramine—Mediastinal disorder—Doxorubicin—testicular cancer	6.84e-05	0.000383	CcSEcCtD
Clomipramine—Leukopenia—Methotrexate—testicular cancer	6.83e-05	0.000383	CcSEcCtD
Clomipramine—Chills—Doxorubicin—testicular cancer	6.81e-05	0.000381	CcSEcCtD
Clomipramine—Arrhythmia—Doxorubicin—testicular cancer	6.78e-05	0.00038	CcSEcCtD
Clomipramine—ADRA2A—lymph node—testicular cancer	6.78e-05	0.0141	CbGeAlD
Clomipramine—Nausea—Cisplatin—testicular cancer	6.74e-05	0.000378	CcSEcCtD
Clomipramine—Vision blurred—Epirubicin—testicular cancer	6.73e-05	0.000377	CcSEcCtD
Clomipramine—Alopecia—Doxorubicin—testicular cancer	6.71e-05	0.000376	CcSEcCtD
Clomipramine—Cough—Methotrexate—testicular cancer	6.66e-05	0.000373	CcSEcCtD
Clomipramine—Mental disorder—Doxorubicin—testicular cancer	6.65e-05	0.000372	CcSEcCtD
Clomipramine—Ill-defined disorder—Epirubicin—testicular cancer	6.63e-05	0.000371	CcSEcCtD
Clomipramine—Convulsion—Methotrexate—testicular cancer	6.61e-05	0.00037	CcSEcCtD
Clomipramine—Vomiting—Etoposide—testicular cancer	6.61e-05	0.00037	CcSEcCtD
Clomipramine—Malnutrition—Doxorubicin—testicular cancer	6.61e-05	0.00037	CcSEcCtD
Clomipramine—Anaemia—Epirubicin—testicular cancer	6.6e-05	0.00037	CcSEcCtD
Clomipramine—Agitation—Epirubicin—testicular cancer	6.57e-05	0.000368	CcSEcCtD
Clomipramine—Rash—Etoposide—testicular cancer	6.56e-05	0.000367	CcSEcCtD
Clomipramine—Dermatitis—Etoposide—testicular cancer	6.55e-05	0.000367	CcSEcCtD
Clomipramine—Headache—Etoposide—testicular cancer	6.52e-05	0.000365	CcSEcCtD
Clomipramine—Flatulence—Doxorubicin—testicular cancer	6.51e-05	0.000365	CcSEcCtD
Clomipramine—Chest pain—Methotrexate—testicular cancer	6.5e-05	0.000364	CcSEcCtD
Clomipramine—Arthralgia—Methotrexate—testicular cancer	6.5e-05	0.000364	CcSEcCtD
Clomipramine—Myalgia—Methotrexate—testicular cancer	6.5e-05	0.000364	CcSEcCtD
Clomipramine—Tension—Doxorubicin—testicular cancer	6.49e-05	0.000363	CcSEcCtD
Clomipramine—Dysgeusia—Doxorubicin—testicular cancer	6.47e-05	0.000362	CcSEcCtD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	6.45e-05	0.000361	CcSEcCtD
Clomipramine—Malaise—Epirubicin—testicular cancer	6.44e-05	0.000361	CcSEcCtD
Clomipramine—Discomfort—Methotrexate—testicular cancer	6.42e-05	0.00036	CcSEcCtD
Clomipramine—Nervousness—Doxorubicin—testicular cancer	6.42e-05	0.000359	CcSEcCtD
Clomipramine—Vertigo—Epirubicin—testicular cancer	6.42e-05	0.000359	CcSEcCtD
Clomipramine—Syncope—Epirubicin—testicular cancer	6.41e-05	0.000359	CcSEcCtD
Clomipramine—Leukopenia—Epirubicin—testicular cancer	6.4e-05	0.000358	CcSEcCtD
Clomipramine—Back pain—Doxorubicin—testicular cancer	6.39e-05	0.000358	CcSEcCtD
Clomipramine—Muscle spasms—Doxorubicin—testicular cancer	6.36e-05	0.000356	CcSEcCtD
Clomipramine—Palpitations—Epirubicin—testicular cancer	6.31e-05	0.000353	CcSEcCtD
Clomipramine—Confusional state—Methotrexate—testicular cancer	6.28e-05	0.000352	CcSEcCtD
Clomipramine—Loss of consciousness—Epirubicin—testicular cancer	6.28e-05	0.000352	CcSEcCtD
Clomipramine—Cough—Epirubicin—testicular cancer	6.23e-05	0.000349	CcSEcCtD
Clomipramine—Anaphylactic shock—Methotrexate—testicular cancer	6.23e-05	0.000349	CcSEcCtD
Clomipramine—Vision blurred—Doxorubicin—testicular cancer	6.23e-05	0.000349	CcSEcCtD
Clomipramine—Convulsion—Epirubicin—testicular cancer	6.19e-05	0.000347	CcSEcCtD
Clomipramine—Nausea—Etoposide—testicular cancer	6.18e-05	0.000346	CcSEcCtD
Clomipramine—Hypertension—Epirubicin—testicular cancer	6.17e-05	0.000345	CcSEcCtD
Clomipramine—Ill-defined disorder—Doxorubicin—testicular cancer	6.13e-05	0.000343	CcSEcCtD
Clomipramine—Nervous system disorder—Methotrexate—testicular cancer	6.11e-05	0.000342	CcSEcCtD
Clomipramine—Anaemia—Doxorubicin—testicular cancer	6.11e-05	0.000342	CcSEcCtD
Clomipramine—Thrombocytopenia—Methotrexate—testicular cancer	6.1e-05	0.000342	CcSEcCtD
Clomipramine—Arthralgia—Epirubicin—testicular cancer	6.08e-05	0.000341	CcSEcCtD
Clomipramine—Chest pain—Epirubicin—testicular cancer	6.08e-05	0.000341	CcSEcCtD
Clomipramine—Myalgia—Epirubicin—testicular cancer	6.08e-05	0.000341	CcSEcCtD
Clomipramine—Agitation—Doxorubicin—testicular cancer	6.07e-05	0.00034	CcSEcCtD
Clomipramine—Anxiety—Epirubicin—testicular cancer	6.06e-05	0.000339	CcSEcCtD
Clomipramine—Skin disorder—Methotrexate—testicular cancer	6.05e-05	0.000339	CcSEcCtD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	6.04e-05	0.000338	CcSEcCtD
Clomipramine—Hyperhidrosis—Methotrexate—testicular cancer	6.02e-05	0.000337	CcSEcCtD
Clomipramine—Discomfort—Epirubicin—testicular cancer	6.01e-05	0.000336	CcSEcCtD
Clomipramine—Malaise—Doxorubicin—testicular cancer	5.96e-05	0.000334	CcSEcCtD
Clomipramine—Dry mouth—Epirubicin—testicular cancer	5.95e-05	0.000333	CcSEcCtD
Clomipramine—Vertigo—Doxorubicin—testicular cancer	5.94e-05	0.000333	CcSEcCtD
Clomipramine—Anorexia—Methotrexate—testicular cancer	5.94e-05	0.000333	CcSEcCtD
Clomipramine—Syncope—Doxorubicin—testicular cancer	5.93e-05	0.000332	CcSEcCtD
Clomipramine—Leukopenia—Doxorubicin—testicular cancer	5.92e-05	0.000331	CcSEcCtD
Clomipramine—Confusional state—Epirubicin—testicular cancer	5.88e-05	0.000329	CcSEcCtD
Clomipramine—ABCB1—female gonad—testicular cancer	5.87e-05	0.0122	CbGeAlD
Clomipramine—Palpitations—Doxorubicin—testicular cancer	5.84e-05	0.000327	CcSEcCtD
Clomipramine—Anaphylactic shock—Epirubicin—testicular cancer	5.83e-05	0.000326	CcSEcCtD
Clomipramine—Oedema—Epirubicin—testicular cancer	5.83e-05	0.000326	CcSEcCtD
Clomipramine—Hypotension—Methotrexate—testicular cancer	5.82e-05	0.000326	CcSEcCtD
Clomipramine—Loss of consciousness—Doxorubicin—testicular cancer	5.81e-05	0.000325	CcSEcCtD
Clomipramine—Cough—Doxorubicin—testicular cancer	5.77e-05	0.000323	CcSEcCtD
Clomipramine—Shock—Epirubicin—testicular cancer	5.74e-05	0.000321	CcSEcCtD
Clomipramine—Convulsion—Doxorubicin—testicular cancer	5.73e-05	0.000321	CcSEcCtD
Clomipramine—Nervous system disorder—Epirubicin—testicular cancer	5.72e-05	0.00032	CcSEcCtD
Clomipramine—Thrombocytopenia—Epirubicin—testicular cancer	5.71e-05	0.00032	CcSEcCtD
Clomipramine—Hypertension—Doxorubicin—testicular cancer	5.71e-05	0.00032	CcSEcCtD
Clomipramine—Tachycardia—Epirubicin—testicular cancer	5.69e-05	0.000319	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Methotrexate—testicular cancer	5.68e-05	0.000318	CcSEcCtD
Clomipramine—Skin disorder—Epirubicin—testicular cancer	5.66e-05	0.000317	CcSEcCtD
Clomipramine—Hyperhidrosis—Epirubicin—testicular cancer	5.64e-05	0.000316	CcSEcCtD
Clomipramine—Insomnia—Methotrexate—testicular cancer	5.64e-05	0.000316	CcSEcCtD
Clomipramine—Chest pain—Doxorubicin—testicular cancer	5.63e-05	0.000315	CcSEcCtD
Clomipramine—Arthralgia—Doxorubicin—testicular cancer	5.63e-05	0.000315	CcSEcCtD
Clomipramine—Myalgia—Doxorubicin—testicular cancer	5.63e-05	0.000315	CcSEcCtD
Clomipramine—Anxiety—Doxorubicin—testicular cancer	5.61e-05	0.000314	CcSEcCtD
Clomipramine—Paraesthesia—Methotrexate—testicular cancer	5.59e-05	0.000313	CcSEcCtD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	5.59e-05	0.000313	CcSEcCtD
Clomipramine—Discomfort—Doxorubicin—testicular cancer	5.56e-05	0.000311	CcSEcCtD
Clomipramine—Anorexia—Epirubicin—testicular cancer	5.56e-05	0.000311	CcSEcCtD
Clomipramine—Dyspnoea—Methotrexate—testicular cancer	5.55e-05	0.000311	CcSEcCtD
Clomipramine—Somnolence—Methotrexate—testicular cancer	5.54e-05	0.00031	CcSEcCtD
Clomipramine—Dry mouth—Doxorubicin—testicular cancer	5.5e-05	0.000308	CcSEcCtD
Clomipramine—Dyspepsia—Methotrexate—testicular cancer	5.48e-05	0.000307	CcSEcCtD
Clomipramine—Hypotension—Epirubicin—testicular cancer	5.45e-05	0.000305	CcSEcCtD
Clomipramine—Confusional state—Doxorubicin—testicular cancer	5.44e-05	0.000305	CcSEcCtD
Clomipramine—Decreased appetite—Methotrexate—testicular cancer	5.42e-05	0.000303	CcSEcCtD
Clomipramine—Anaphylactic shock—Doxorubicin—testicular cancer	5.4e-05	0.000302	CcSEcCtD
Clomipramine—Oedema—Doxorubicin—testicular cancer	5.4e-05	0.000302	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Methotrexate—testicular cancer	5.38e-05	0.000301	CcSEcCtD
Clomipramine—Fatigue—Methotrexate—testicular cancer	5.37e-05	0.000301	CcSEcCtD
Clomipramine—Pain—Methotrexate—testicular cancer	5.33e-05	0.000298	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Epirubicin—testicular cancer	5.31e-05	0.000297	CcSEcCtD
Clomipramine—Shock—Doxorubicin—testicular cancer	5.31e-05	0.000297	CcSEcCtD
Clomipramine—Nervous system disorder—Doxorubicin—testicular cancer	5.29e-05	0.000296	CcSEcCtD
Clomipramine—Thrombocytopenia—Doxorubicin—testicular cancer	5.28e-05	0.000296	CcSEcCtD
Clomipramine—Insomnia—Epirubicin—testicular cancer	5.27e-05	0.000295	CcSEcCtD
Clomipramine—Tachycardia—Doxorubicin—testicular cancer	5.27e-05	0.000295	CcSEcCtD
Clomipramine—Skin disorder—Doxorubicin—testicular cancer	5.24e-05	0.000293	CcSEcCtD
Clomipramine—Paraesthesia—Epirubicin—testicular cancer	5.24e-05	0.000293	CcSEcCtD
Clomipramine—Hyperhidrosis—Doxorubicin—testicular cancer	5.22e-05	0.000292	CcSEcCtD
Clomipramine—ABCB1—testis—testicular cancer	5.21e-05	0.0108	CbGeAlD
Clomipramine—Dyspnoea—Epirubicin—testicular cancer	5.2e-05	0.000291	CcSEcCtD
Clomipramine—Somnolence—Epirubicin—testicular cancer	5.18e-05	0.00029	CcSEcCtD
Clomipramine—Anorexia—Doxorubicin—testicular cancer	5.14e-05	0.000288	CcSEcCtD
Clomipramine—Feeling abnormal—Methotrexate—testicular cancer	5.13e-05	0.000287	CcSEcCtD
Clomipramine—Dyspepsia—Epirubicin—testicular cancer	5.13e-05	0.000287	CcSEcCtD
Clomipramine—Gastrointestinal pain—Methotrexate—testicular cancer	5.09e-05	0.000285	CcSEcCtD
Clomipramine—Decreased appetite—Epirubicin—testicular cancer	5.07e-05	0.000284	CcSEcCtD
Clomipramine—Hypotension—Doxorubicin—testicular cancer	5.04e-05	0.000282	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Epirubicin—testicular cancer	5.03e-05	0.000282	CcSEcCtD
Clomipramine—Fatigue—Epirubicin—testicular cancer	5.03e-05	0.000281	CcSEcCtD
Clomipramine—Pain—Epirubicin—testicular cancer	4.99e-05	0.000279	CcSEcCtD
Clomipramine—Constipation—Epirubicin—testicular cancer	4.99e-05	0.000279	CcSEcCtD
Clomipramine—Urticaria—Methotrexate—testicular cancer	4.95e-05	0.000277	CcSEcCtD
Clomipramine—Abdominal pain—Methotrexate—testicular cancer	4.93e-05	0.000276	CcSEcCtD
Clomipramine—Body temperature increased—Methotrexate—testicular cancer	4.93e-05	0.000276	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Doxorubicin—testicular cancer	4.92e-05	0.000275	CcSEcCtD
Clomipramine—Insomnia—Doxorubicin—testicular cancer	4.88e-05	0.000273	CcSEcCtD
Clomipramine—Paraesthesia—Doxorubicin—testicular cancer	4.84e-05	0.000271	CcSEcCtD
Clomipramine—Dyspnoea—Doxorubicin—testicular cancer	4.81e-05	0.000269	CcSEcCtD
Clomipramine—Feeling abnormal—Epirubicin—testicular cancer	4.8e-05	0.000269	CcSEcCtD
Clomipramine—Somnolence—Doxorubicin—testicular cancer	4.8e-05	0.000269	CcSEcCtD
Clomipramine—Gastrointestinal pain—Epirubicin—testicular cancer	4.77e-05	0.000267	CcSEcCtD
Clomipramine—Dyspepsia—Doxorubicin—testicular cancer	4.75e-05	0.000266	CcSEcCtD
Clomipramine—Decreased appetite—Doxorubicin—testicular cancer	4.69e-05	0.000263	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Doxorubicin—testicular cancer	4.66e-05	0.000261	CcSEcCtD
Clomipramine—Fatigue—Doxorubicin—testicular cancer	4.65e-05	0.00026	CcSEcCtD
Clomipramine—Urticaria—Epirubicin—testicular cancer	4.63e-05	0.000259	CcSEcCtD
Clomipramine—Pain—Doxorubicin—testicular cancer	4.61e-05	0.000258	CcSEcCtD
Clomipramine—Constipation—Doxorubicin—testicular cancer	4.61e-05	0.000258	CcSEcCtD
Clomipramine—Body temperature increased—Epirubicin—testicular cancer	4.61e-05	0.000258	CcSEcCtD
Clomipramine—Abdominal pain—Epirubicin—testicular cancer	4.61e-05	0.000258	CcSEcCtD
Clomipramine—Hypersensitivity—Methotrexate—testicular cancer	4.59e-05	0.000257	CcSEcCtD
Clomipramine—Asthenia—Methotrexate—testicular cancer	4.47e-05	0.00025	CcSEcCtD
Clomipramine—Feeling abnormal—Doxorubicin—testicular cancer	4.45e-05	0.000249	CcSEcCtD
Clomipramine—Gastrointestinal pain—Doxorubicin—testicular cancer	4.41e-05	0.000247	CcSEcCtD
Clomipramine—Pruritus—Methotrexate—testicular cancer	4.41e-05	0.000247	CcSEcCtD
Clomipramine—Hypersensitivity—Epirubicin—testicular cancer	4.3e-05	0.000241	CcSEcCtD
Clomipramine—Urticaria—Doxorubicin—testicular cancer	4.29e-05	0.00024	CcSEcCtD
Clomipramine—Abdominal pain—Doxorubicin—testicular cancer	4.26e-05	0.000239	CcSEcCtD
Clomipramine—Body temperature increased—Doxorubicin—testicular cancer	4.26e-05	0.000239	CcSEcCtD
Clomipramine—Diarrhoea—Methotrexate—testicular cancer	4.26e-05	0.000239	CcSEcCtD
Clomipramine—Asthenia—Epirubicin—testicular cancer	4.18e-05	0.000234	CcSEcCtD
Clomipramine—Pruritus—Epirubicin—testicular cancer	4.13e-05	0.000231	CcSEcCtD
Clomipramine—Dizziness—Methotrexate—testicular cancer	4.12e-05	0.000231	CcSEcCtD
Clomipramine—Diarrhoea—Epirubicin—testicular cancer	3.99e-05	0.000223	CcSEcCtD
Clomipramine—Hypersensitivity—Doxorubicin—testicular cancer	3.97e-05	0.000223	CcSEcCtD
Clomipramine—Vomiting—Methotrexate—testicular cancer	3.96e-05	0.000222	CcSEcCtD
Clomipramine—Rash—Methotrexate—testicular cancer	3.93e-05	0.00022	CcSEcCtD
Clomipramine—Dermatitis—Methotrexate—testicular cancer	3.92e-05	0.00022	CcSEcCtD
Clomipramine—Headache—Methotrexate—testicular cancer	3.9e-05	0.000219	CcSEcCtD
Clomipramine—Asthenia—Doxorubicin—testicular cancer	3.87e-05	0.000217	CcSEcCtD
Clomipramine—Dizziness—Epirubicin—testicular cancer	3.86e-05	0.000216	CcSEcCtD
Clomipramine—Pruritus—Doxorubicin—testicular cancer	3.82e-05	0.000214	CcSEcCtD
Clomipramine—ABCB1—lymph node—testicular cancer	3.78e-05	0.00784	CbGeAlD
Clomipramine—Vomiting—Epirubicin—testicular cancer	3.71e-05	0.000208	CcSEcCtD
Clomipramine—Nausea—Methotrexate—testicular cancer	3.7e-05	0.000207	CcSEcCtD
Clomipramine—Diarrhoea—Doxorubicin—testicular cancer	3.69e-05	0.000207	CcSEcCtD
Clomipramine—Rash—Epirubicin—testicular cancer	3.68e-05	0.000206	CcSEcCtD
Clomipramine—Dermatitis—Epirubicin—testicular cancer	3.67e-05	0.000206	CcSEcCtD
Clomipramine—Headache—Epirubicin—testicular cancer	3.65e-05	0.000205	CcSEcCtD
Clomipramine—Dizziness—Doxorubicin—testicular cancer	3.57e-05	0.0002	CcSEcCtD
Clomipramine—Nausea—Epirubicin—testicular cancer	3.46e-05	0.000194	CcSEcCtD
Clomipramine—Vomiting—Doxorubicin—testicular cancer	3.43e-05	0.000192	CcSEcCtD
Clomipramine—Rash—Doxorubicin—testicular cancer	3.4e-05	0.00019	CcSEcCtD
Clomipramine—Dermatitis—Doxorubicin—testicular cancer	3.4e-05	0.00019	CcSEcCtD
Clomipramine—Headache—Doxorubicin—testicular cancer	3.38e-05	0.000189	CcSEcCtD
Clomipramine—Nausea—Doxorubicin—testicular cancer	3.2e-05	0.000179	CcSEcCtD
